Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2009 / Cilt: 6 - Sayı: 3

Neural tube defects and pregnancy

Gebelik ve nöral tüp defektleri

Pages
193–196
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Education of the mother and periconceptional folic acid usage may reduce teh incidence of NTD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Neural tube defects are congenital malformations those mostly causing life-long morbidities.
📊
Key Findings & Data:RESULTS: In our obstetrics clinic 1403 delivery were made and 43 of them had fetus with NTD.
💡
Conclusion & Impact:Education of the mother and periconceptional folic acid usage may reduce teh incidence of NTD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Neural tube defects are congenital malformations those mostly causing life-long morbidities. They are prevented by the periconseptional folic acid usage and prenatal diagnostic methods. MATERIALS-METHODS: Pregnants from Afyonkarahisar and neighbourhood cities applied to our hospital and determined NTD, were investigated. RESULTS: In our obstetrics clinic 1403 delivery were made and 43 of them had fetus with NTD. Among these fetuses 41.3% had meningomyelocel, 17.4% had meningocel, 21.7% had encephalocel, 8.7% had unencephali and 4.3% had iniencephali. CONCLUSION: Incidence of NTD is high in our region and geographic region, nutrition and other socioeconomic factors may be related to the high incidence. Education of the mother and periconceptional folic acid usage may reduce teh incidence of NTD.

Özet

AMAÇ: Nöral tüp defektleri (NTD) çoğu zaman yaşam boyu kalıcı deformitelere yol açan doğumsal malformasyonlardır. Perikonsepsiyonel folik asit kullanımı ve prenatal tanı yöntemleriyle önlenebilmektedir. Gereç ve YÖNTEMLER: Afyonkarahisar ve çevre illerden hastanemize başvuran ve NTD saptanan gebeler incelenmiştir. BULGULAR: Kadın Hastalıkları ve Doğum servisimizde 1403 adet doğum olup, bunlardan 43 tanesi NTD’li fetüs doğurmuştur. Fetüsların %41,3’ü meningomyelosel, %17,4’ü meningosel, %21,7’si ensefalosel, %8,7’si anensefali, %4,3’ü iniensefali olarak değerlendirildi. SONUÇ: Bölgemizde NTD sık görülmekte olup coğrafi bölgeler, beslenme ve diğer sosyoekonomik faktörler bu sıklıkta etkili olabilir. Anne eğitimi ve perikonsepsiyonel dönemde düzenli folik asit alımının sağlanması NTD sıklığını azaltacaktır.

🔖

Cite This Article

YILMAZER, M., KÖKEN, G., ŞAHİN, F. K., ARIÖZ, D. T., COŞAR, E., KÖKEN, R., MELEK, H., YEŞİLDAĞER, E. (2022). Neural tube defects and pregnancy. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 6 - Sayı: 3, 193–196. https://ajindex.com/articles/631678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Tunçbilek E, Boduroğlu K, Alikasifoglu M. Neural tube defects in Turkey: prevalence, distrubition and risk factors. Turk J Pediatr 1999; 41: 299- 305
  2. Shutleff DB, Graaf WD. Overwiew of clinical issues in the management of myelomeningocele. In: Sarwark JF, Lubicky JP, eds. Caring for the child with spina bifida. 1st ed. Illınois: Published by American Academy of Orthopaedic Surgeons; 2001 p 1- 11
  3. Tunçbilek E. Türkiye’deki yüksek nöral tüp defekti sıklığı ve önlemek için yapılabilecekler. Çocuk Sağlığı ve Hastalıkları Dergisi 2004; 47: 79- 84
  4. Food and Drug Administration. Food Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid. Final Rule 21 CFR Parts 136,137 and 139 1996; 131: 3702- 37
  5. Turan JM, Say L, Bulut A. Nöral tüp defektlerinin önlenmesinde folik asit kullanımı. Steed 2000; 9: 288- 90
  6. Tunçbilek E, Alikaşifoğlu M, Akadlı B, Hancıoğlu A, Boduroğlu K. Türkiye’de konjenital malformasyon sıklığı, dağılımı, risk faktörleri ve yenidoğanların antropometrik değerlendirilmesi. Ankara: TUB‹TAK Matbaası 1996: 945
  7. Mortimer EA. The puzzling epidemiology of neural tube defects. Pediatrics 1980; 65: 63640
  8. Kılıç M, Taşkın E, Doğan Y, Aygün AD. Yenidoğan ünitesinde izlenen nöral tüp defektli bebeklerin değerlendirilmesi. Çocuk Dergisi 2003; 3: 131- 5
  9. Expert advisory group. Folic acid and the prevention of neural tube defect. London: Department of Health, 1992
  10. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992; 4: 17
  11. Czeizel AE. Primary prevention of neural tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy. Paediatr Drugs 2000; 2: 437- 49
  12. Bailey LB, Rampersand GC, Kanwell GP. Folic acid supplements and fortication affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr 2003; 133: 1961S-8S
  13. Özgünen FT. Nöral Tüp Defektleri ve Down Sendromunun Biyokimyasal testlerle taranması. T Klin Jinekol Obst 2002; 12: 348- 54
  14. Vintzileos AM, Ananth CV, Fisher AJ. Cost benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second trimester maternal seru alpha-fetoprotein. Am J Obstet Gynecol 1999; 180: 1227- 33
  15. Peralta CF, Bunduki V, Plese JP, Figueiredo EG, Miguelez J, Zugaib M. Association b